Pancreatic ductal adenocarcinoma contains an effector and regulatory immune cell infiltrate that is altered by multimodal neoadjuvant treatment.

Por Kendall C Shibuya, Vikas K Goel, Wei Xiong, Jonathan G Sham, Seth M Pollack, Allison M Leahy, Samuel H Whiting, Matthew M Yeh, Cassian Yee, Stanley R Riddell, Venu G Pillarisetty
Publicado em 2014-01-01